Khadhouri, SinanGallagher, Kevin M.MacKenzie, KennethShah, Taimur T.Gao, ChuanyuMoore, SachaZimmermann, EleanorEdison, EricJefferies, MatthewNambiar, Arjun K.Mannas, MilesLee , TaeweonMarra , GiancarloLillaz , BeatriceGómez Rivas, Juanolivier, JonathanAssmus , MarkUçar, TahaClaps, FrancescoBoltri , MatteoBurnhope, TaraNkwam, NkwamTanasescu, GeorgeBoxall, NicholasDowney , AlisonLal, AsimAntón-Juanilla , MartaClarke, HollyLau, DavidGillams , KathrynCrockett, MatthewNielsen, Matthew E.Takwoingi, YemisiChuchu , NaomiO'Rourke, JohnMacLennan, GraemeMcGrath, JohnKasivisvanathan, VeeruThe IDENTIFY Study Group2021-09-282021-09-282021-10-01Khadhouri, S, Gallagher, K M, MacKenzie, K, Shah, T T, Gao, C, Moore, S, Zimmermann, E, Edison, E, Jefferies, M, Nambiar, A K, Mannas, M, Lee , T, Marra , G, Lillaz , B, Gómez Rivas, J, olivier, J, Assmus , M, Uçar, T, Claps, F, Boltri , M, Burnhope, T, Nkwam, N, Tanasescu, G, Boxall, N, Downey , A, Lal, A, Antón-Juanilla , M, Clarke, H, Lau, D, Gillams , K, Crockett, M, Nielsen, M E, Takwoingi, Y, Chuchu , N, O'Rourke, J, MacLennan, G, McGrath, J, Kasivisvanathan, V & The IDENTIFY Study Group 2021, 'The IDENTIFY Study : The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicentre observational study', BJU International, vol. 128, no. 4, pp. 440-450. https://doi.org/10.1111/bju.154831464-4096Jisc: 3a9e72782ccb44d68b4aa4fbd8997c6bORCID: /0000-0002-1039-5646/work/99981696https://hdl.handle.net/2164/17185Funding Grants from Action Bladder Cancer UK, The Urology Foundation, The Rosetrees Trust were used for costs of statistical analysis and dissemination of results at international meetings and conferences. There were no endorsements from pharmaceutical companies or agencies to write this article. The corresponding author (Sinan Khadhouri) had full access to the data and held the final responsibility to submit the manuscript. Action Bladder Cancer UK, The Urology Foundation, The Rosetrees Trust.121170598engSubstantive connection via an eligible employment contractSDG 3 - Good Health and Well-beinghaematuriabladder cancerupper tract urothelial cancerrenal cancercancer prevalenceurinary tract cancerprostate cancerR MedicineOtherSupplementary InformationRJournal article10.1111/bju.15483